Last reviewed · How we verify

NCT02518308

Mindfulness Intervention in Reducing Anxiety in Patients Who Have Been Treated for Gynecologic Cancer

Completed NA Last updated 15 November 2019
What this trial tests

NA trial testing Mindfulness-Based Stress Reduction in Anxiety in 38 participants. Completed in 20 June 2019.

Timeline
18 November 2015
Primary endpoint
20 June 2019
20 June 2019

Quick facts

Lead sponsorUniversity of Wisconsin, Madison
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment38
Start date18 November 2015
Primary completion20 June 2019
Estimated completion20 June 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Wisconsin, Madison

Who can join

18 and older, female only, with Anxiety or Cancer Survivor. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot clinical trial studies how well a mindfulness-based stress reduction (MBSR) intervention works in reducing anxiety in patients who have undergone treatment for gynecologic cancer but no longer have any sign of disease. Gynecologic cancer is cancer of the female reproductive tract, which includes the cervix, endometrium, fallopian tubes, ovaries, uterus, and vagina. Side effects from treatment for these cancers may include anxiety, fatigue, depression, and sexual function changes. Mindfulness training uses meditation and yoga to help patients focus on breathing, bodily sensations, and mental awareness. This may help decrease patients' stress and anxiety and improve their quality of life, and may also help their immune system.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Mindfulness-Based Stress Reduction

Trials testing the same drug.

Other recruiting trials for Anxiety

Currently open trials in the same condition.

Other University of Wisconsin, Madison trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02518308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing